2024-2025 Global AI Trends Guide
The U.S. Department of Health and Human Services (HHS) has finalized amendments to more closely align the Part 2 substance use disorder (SUD) regulations with HIPAA. These changes have the potential to streamline compliance efforts for HIPAA-covered SUD providers. The regulations require all SUD providers to revise policies and procedures and patient consent processes, among other compliance measures. Although the updates take effect April 16, 2024, SUD providers have until February 16, 2026, to come into compliance with new requirements.
This final rule, announced by the HHS Substance Abuse and Mental Health Services Administration (SAMHSA) and Office for Civil Rights (OCR), implements provisions of the March 2020 CARES Act that have important implications for SUD providers. Many of the changes introduced by the final rule were previewed in HHS’ December 2, 2022, Notice of Proposed Rulemaking (NRPM), as outlined in our prior post.
In a webinar hosted by HHS on February 9, 2024, HHS advised that that it will conduct outreach and develop guidance on how to comply with the new requirements. HHS also shared plans to finalize changes to the HIPAA Notice of Privacy Practices (NPP) requirements, including provisions to address uses and disclosures of PHI that are also protected by Part 2, in an upcoming final rule modifying the HIPAA Privacy Rule, which we discussed in this previous post.
A key aim of the Part 2 modifications is to simplify compliance efforts and facilitate care coordination, particularly for SUD providers regulated by both Part 2 and HIPAA. Prior to these changes, complying with both regulations required complex strategies and uneven treatment of different patient records. For example, while HIPAA allows for disclosures of PHI for treatment, payment, and healthcare operations without patient authorization, Part 2 records could only be disclosed with patient consent. To address this inconsistency, the final rule allows a single consent for all future uses and disclosures of Part 2 records for treatment, payment, and health care operations, and allows HIPAA-regulated entities that receive records under this consent to redisclose the records in accordance with the HIPAA regulations. This alignment with HIPAA allows providers to more effectively coordinate patient care.
The final rule makes additional changes related to patient consent, including:
The final rule includes additional obligations that align with HIPAA, including:
In addition, the final rule makes clear that segregating or segmenting Part 2 records is not required.
Part 2 programs may need to modify their practices to ensure compliance with the new requirements and consider:
Authored by Melissa Bianchi, Melissa Levine, Donald DePass, and Fleur Oké